CSI Market
Sign In | Register

Charles River Laboratories International inc (CRL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CRL Annual Cash Flow →
Tracking cash flow results across Charles River Laboratories International inc to Jun 28 2025 helps illustrate how Jun 27 2026's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 27 2026)
6 Months 		(Mar 28 2026) (Dec 27 2025) (Sep 27 2025) (Jun 28 2025)
Operating Activities
Income-15.56
Depreciation & amortization134.44
Amortization of Other Assets29.93
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use135.55
Provision For Loan Losses Expensed1.12
Inventories Decrease /-Increase-40.58
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-142.90
Share-based Compensation42.16
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Increase Decrease In Contract With Customer Liability5.20
Venture Capital And Equity Method Investments Gain Loss And Impairments Net1.14
Income taxes0.00
Gain (Loss) on Investments, Excluding Other than Temporary Impairments0.00
Accounts Receivable22.28
Increase (Decrease) in Accounts Payable21.28
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital20.34
Other Noncash Income (Expense)12.60
Other net0.76
Payments for (Proceeds from) Other Operating Activities-0.61
Discontinued operations0.00
Net Cash flow from Operating Activities220.80
Investing Activities
Capital Expenditures-87.01
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities11.06
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-11.81
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-467.25
Interest in Subsidiaries and Affiliates0.00
Proceeds from Sales of Business, Affiliate and Productive Assets176.56
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-1.30
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-379.75
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings1,265.26
Long-term debt - repayments-745.93
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-322.26
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-2.61
Other net-11.40
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents216.00
Payments For Additional Equity Interests-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities183.06
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow133.79
Total Cash Flow24.58
4 historic quarters locked

Sign in to unlock the full Charles River Laboratories International inc cash flow history.

Sign In Create Free Account

About Charles River Laboratories International Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260627)
  • Filed with the SEC: August 5, 2026
  • Source: crl-20260627.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001100682-26-000118

Figures are derived from filed reports and may be restated. Historical data is subject to revision.